| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/24/1997 | DE19642043A1 Transdermal therapeutic system for treating drug dependency |
| 04/24/1997 | DE19540475A1 Chirale Methylphenyloxazolidinone Chiral methylphenyloxazolidinones |
| 04/24/1997 | DE19540233A1 Sulfamat-Derivate von 1,3,5(10)-Estratrien-Derivaten, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen Containing sulphamate derivatives of 1,3,5 (10) -estratrien-derivatives, processes for their preparation and pharmaceutical compositions comprising these compounds |
| 04/24/1997 | DE19539361A1 Verfahren zur Herstellung von mehrschichtigen, festen Arzneiformen zur oralen oder rektalen Verabreichung A process for producing multilayer, solid drug forms for oral or rectal administration |
| 04/24/1997 | DE19539233A1 Two-phase oral contraception |
| 04/24/1997 | DE19538960A1 4a,5a,8a,8b-Tetrahydro-6H-pyrrolo [3',4':4,5] furo [3,2-b] pyridin-6,8(7H)-dion Derivate zur Bekämpfung von Endoparasiten, Verfahren zu ihrer Herstellung 4a, 5a, 8a, 8b-tetrahydro-6H-pyrrolo [3 ', 4': 4,5] furo [3,2-b] pyridine-6,8 (7H) -dione derivatives for the control of endoparasites, to processes for their preparation |
| 04/24/1997 | DE19538741A1 Cyclopeptidderivate Cyclopeptide derivatives |
| 04/24/1997 | DE19538687A1 Stabile pharmazeutische Darreichungsformen enthaltend Parathormon The stable pharmaceutical dosage forms containing parathyroid hormone |
| 04/24/1997 | DE19536589A1 Verwendung von Vitamin E und Vitamin C Use of vitamin E and vitamin C |
| 04/24/1997 | CA2235304A1 Pharmaceutically active quinazoline compounds |
| 04/24/1997 | CA2235278A1 Use of protein s-100b in medicines and medicines containing the protein s-100b |
| 04/24/1997 | CA2235257A1 Influenza vaccine |
| 04/24/1997 | CA2235245A1 Low molecular weight cell, bone marrow and immune stimulants |
| 04/24/1997 | CA2235168A1 Synthetic vaccine for protection against human immunodeficiency virus infection |
| 04/24/1997 | CA2235071A1 Analgesic immediate and controlled release pharmaceutical composition |
| 04/24/1997 | CA2234968A1 Topically applied, structural cellulite treatments |
| 04/24/1997 | CA2234967A1 Fibrinogen receptor antagonists |
| 04/24/1997 | CA2234954A1 Multiple vitamin supplement composition |
| 04/24/1997 | CA2234913A1 Cyclopentyl tachykinin receptor antagonists |
| 04/24/1997 | CA2234884A1 Receptor-selective somatostatin analogs |
| 04/24/1997 | CA2234877A1 Herpesvirus vectors and their uses |
| 04/24/1997 | CA2234724A1 Stable pharmaceutical forms of administration containing parathyroid hormone |
| 04/24/1997 | CA2234633A1 Method of detecting cyclooxygenase-2 |
| 04/24/1997 | CA2234244A1 Lipid alcohols as new immunosuppressive and antiviral pharmaceutical agents |
| 04/24/1997 | CA2233084A1 16-substituted-6-aza-steroid 5-.alpha.-reductase inhibitors |
| 04/24/1997 | CA2232609A1 Phenanthridine derivatives, methods of producing them and medicaments containing phenanthridine derivatives |
| 04/24/1997 | CA2229710A1 Amino substituted pyrimidines and triazines |
| 04/24/1997 | CA2188587A1 Support and composition containing said support and a stabilized cosmetic or dermatological ingredient |
| 04/23/1997 | EP0769502A1 Process for producing desulfated polysaccharide, and desulfated heparin |
| 04/23/1997 | EP0769300A2 Antiemetic composition containing an NK-1 receptor antagonists |
| 04/23/1997 | EP0769299A1 Remedy for allergic diseases in the region of the nose |
| 04/23/1997 | EP0769297A1 Use of nefazodone for the manufacture of a medicament for the treatment of panic attack |
| 04/23/1997 | EP0769296A1 Use of isoxazole- and crotonamide derivatives for the manufacture of a medicament for the treatment of cancers |
| 04/23/1997 | EP0769295A1 Therapeutic agent for liver regeneration |
| 04/23/1997 | EP0769294A1 Taste-masked aqueous solutions comprising methol |
| 04/23/1997 | EP0769293A2 Use of at least a beta-adrenergic agonist as an antagonist of substance P |
| 04/23/1997 | EP0769291A1 Active agent combination against acne and inflamed comedones |
| 04/23/1997 | EP0769148A1 Improved methods for the determination and adjustment of prolactin daily rhythms |
| 04/23/1997 | EP0769026A1 Fractionated polydisperse compositions |
| 04/23/1997 | EP0769024A1 High-affinity melatonin receptors and uses thereof |
| 04/23/1997 | EP0769019A1 Helicobacter pylori antigenic protein preparation and immunoassays |
| 04/23/1997 | EP0769018A1 Helicobacter proteins and vaccines |
| 04/23/1997 | EP0769017A1 Therapeutic compounds |
| 04/23/1997 | EP0769012A1 Tetracyclic derivatives and their use as antitumour agents |
| 04/23/1997 | EP0769007A1 2-ureido-benzamide derivatives |
| 04/23/1997 | EP0769006A1 Small molecule inhibitors of rotamase enzyme activity |
| 04/23/1997 | EP0769005A2 Pla 2? inhibitors and their use for inhibition of intestinal cholesterol absorption |
| 04/23/1997 | EP0768898A1 Cascade-polymer complexes and methods of producing the same |
| 04/23/1997 | EP0768897A1 Inclusion complexes of ranitidine |
| 04/23/1997 | EP0768896A2 Low-dose steroid tablets containing gallic acid esters as antioxidant agent, process for the manufacture of said tablets, and uses of said tablets |
| 04/23/1997 | EP0768895A1 Camptothecin drug combinations and medicaments with reduced side effects |
| 04/23/1997 | EP0768889A1 Cancer therapy using lymphotoxin |
| 04/23/1997 | EP0768888A1 Use of muramyl peptide compounds |
| 04/23/1997 | EP0768887A1 Compositions having antiviral properties and preparation process |
| 04/23/1997 | EP0768885A1 Method for inhibiting cancer metastasis by oral administration of soluble modified citrus pectin |
| 04/23/1997 | EP0768884A1 Drugs containing metronidazole or a synergistic mixture of metronidazole and clindamycin |
| 04/23/1997 | EP0768883A1 Pyrimidine nucleotide precursors for treatment of systemic inflammation and inflammatory hepatitis |
| 04/23/1997 | EP0768882A1 Carbamazepine medicament with retarded active substance release |
| 04/23/1997 | EP0768881A2 Anti-hiv triple combination |
| 04/23/1997 | EP0768880A1 Tacrine pharmaceutical compositions |
| 04/23/1997 | EP0768879A1 Use of thiazole and thiadiazole compounds as d3 dopamine receptor ligands |
| 04/23/1997 | EP0768878A1 Endothelin receptor antagonists |
| 04/23/1997 | EP0768877A1 Antikeratolytic-wound healing compositions and methods for preparing and using same |
| 04/23/1997 | EP0768876A1 Stable oil-in-water emulsions incorporating a taxine (taxol) and method of making same |
| 04/23/1997 | EP0768875A1 Nitric oxide synthase inhibitors for inhibiting the production of airway mucus |
| 04/23/1997 | EP0768874A1 Pharmaceutical compositions containing Triclosan or derivates thereof and Edta or Egta |
| 04/23/1997 | EP0768872A1 New oral pharmaceutical formulation containing magnesium salt of omeprazole |
| 04/23/1997 | EP0768868A1 Pharmaceutical preparation with a hydrophobic active substance and an effervescent system, and process for preparing said preparation |
| 04/23/1997 | EP0768866A1 Desquamation compositions |
| 04/23/1997 | EP0768821A1 pp60PIK : A DOWNSTREAM ELEMENT IN INSULIN SIGNALING |
| 04/23/1997 | EP0768819A1 Combined virustatic antimediator (covam) treatment of common colds |
| 04/23/1997 | EP0708627A4 Method and device for providing nicotine replacement therapy transdermally/transbuccally |
| 04/23/1997 | EP0670825B1 Nitric esters having a pharmacological activity and process for their preparation |
| 04/23/1997 | EP0663903B1 1,2-dihydro-2-oxo-3-amino quinoxaline derivatives, preparation thereof and application in therapy |
| 04/23/1997 | EP0656844B1 Crank mechanism for a windscreen wiper drive of a motor vehicle |
| 04/23/1997 | EP0654036B1 Liponucleotides of seco-nucleosides, their preparation and their use as anti-viral drugs |
| 04/23/1997 | EP0651754B1 K-252a DERIVATIVES |
| 04/23/1997 | EP0637243B1 Novel aminosterol antibiotic |
| 04/23/1997 | EP0626942B1 Bicyclo[2.2.2.]octane derivatives as cholestocystokinin inhibitors |
| 04/23/1997 | EP0623123B1 Benzopyran and related LTB4-antagonists |
| 04/23/1997 | EP0600873B1 Therapeutically effective topical application of st1435 |
| 04/23/1997 | EP0505374B1 Vitamin-mineral treatment methods and compositions |
| 04/23/1997 | CN1148391A Increased bioavailability of biologically active compounds by linking to polypyrrolecarboxamido-naphthalene derivatives |
| 04/23/1997 | CN1148389A Diaryl 5,6-fused heterocyclic acids as leukotriene antagonists |
| 04/23/1997 | CN1148387A Substd. aminoalkylaminopyridine |
| 04/23/1997 | CN1148384A Chelant compounds |
| 04/23/1997 | CN1148380A 22-thiavitamin D3 derivative |
| 04/23/1997 | CN1148344A New oral pharmaceutical dosage form |
| 04/23/1997 | CN1148341A Oral liquid alendronate formulations |
| 04/23/1997 | CN1148340A Method for treating 5HT2B receptor related conditions |
| 04/23/1997 | CN1148339A Thiadiazoles and their use as antipicornaviral agent |
| 04/23/1997 | CN1148338A Increasing fetal hemoglobin level using carboxylic esters |
| 04/23/1997 | CN1148337A Compound active at a novel site on receptor-operated calcium channels usefull for treatment of neurological disorders and diseases |
| 04/23/1997 | CN1148335A Mucoadhesive emulsion contg. cyclodextrin |
| 04/23/1997 | CN1148334A Gentle anti-acne composition |
| 04/23/1997 | CN1148047A Derivatives of 12,13-epoxy-tylosin and processes of mfr. thereof |
| 04/23/1997 | CN1148042A New heterocyclically substituted pseudopeptides |
| 04/23/1997 | CN1147937A Use of sertraline to treat post myocardial infraction patients |
| 04/23/1997 | CN1147902A Zilpaterol hydrochloride in specific crystallized form, its prepn. process and intermediate products used |
| 04/23/1997 | CN1034663C Method for preparing hemoregulatory peptides |